ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

STEPHANIE SARRAT MD

2633 NAPOLEON AVE STE 400, ATTN DRS. LOUAPRE, KOKEMORE & SARRAT LLC

New orleans | Louisiana | 70115

(504) 897-3305

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,850Medicare Part D Prescriptions Filled, Including Refills

Rank: 171 out of 680

$988K Total Retail Price of All Prescriptions

Rank: 84 out of 680

802 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 10,447 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
ATORVASTATIN CALCIUM 632 561 1 11
AMLODIPINE BESYLATE 631 572 2 1
SIMVASTATIN 580 526 3 3
HYDROCHLOROTHIAZIDE 553 506 4 9
BENAZEPRIL HCL 330 288 5 40
LEVOTHYROXINE SODIUM 315 293 6 2
METFORMIN HCL ER 280 256 7 54
BENAZEPRIL-HYDROCHLOROTHIAZIDE 275 260 8 164
LOSARTAN POTASSIUM 255 225 9 21
JANUVIA 249 235 10 60
METOPROLOL SUCCINATE 241 221 11 13
POTASSIUM CHLORIDE 197 188 12 14
LISINOPRIL 191 165 13 5
PANTOPRAZOLE SODIUM 187 153 14 30
AMLODIPINE BESYLATE-BENAZEPRIL 185 185 15 43
NEXIUM 177 136 16 16
TRAMADOL HCL 175 127 17 18
OMEPRAZOLE 172 149 18 7
LORAZEPAM 164 147 19 125
FUROSEMIDE 163 145 20 6
INSULIN SYRINGE 152 124 21 86
METOPROLOL TARTRATE 151 140 22 12
METFORMIN HCL 151 116 22 8
PRAVASTATIN SODIUM 138 111 24 10
ATENOLOL 137 122 25 19
GABAPENTIN 135 125 26 15
ALLOPURINOL 123 104 27 33
GLIMEPIRIDE 117 117 28 29
CITALOPRAM HBR 111 100 29 22
ALENDRONATE SODIUM 105 101 30 32
AZELASTINE HCL 97 83 31 240
DONEPEZIL HCL 89 89 32 27
NIFEDIPINE ER 87 85 33 75
FLUOXETINE HCL 85 61 34 74
ESCITALOPRAM OXALATE 81 72 35 45
PAROXETINE HCL 79 57 36 76
LOVASTATIN 75 72 37 44
CLOPIDOGREL 74 66 38 26
FLUTICASONE PROPIONATE 74 71 38 41
LOSARTAN-HYDROCHLOROTHIAZIDE 72 70 40 51
CARVEDILOL 70 66 41 23
GLIPIZIDE 67 51 42 63
TRIAMTERENE-HCTZ 66 55 43 52
PLAVIX 65 58 44 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 46 44 37
TRAZODONE HCL 64 52 46 48
BENICAR 62 53 47 131
CRESTOR 61 53 48 25
ALPRAZOLAM 60 46 49 72
LANTUS 60 45 49 49
NIFEDICAL XL 59 55 51 220
PROAIR HFA 58 49 52 67
NAPROXEN 57 51 53 121
KLOR-CON 10 52 50 54 184
WARFARIN SODIUM 51 38 55 20
NAMENDA 50 50 56 35
DOXYCYCLINE HYCLATE 50 38 56 95
SYNTHROID 50 37 56 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.